References (Numerical)
  1. Ahmed M, Yassin M A (June 19, 2020) Treatment-Free Remission in Chronic Idiopathic ThrombocytopenicPurpura. Cureus 12(6): e8705. DOI 10.7759/cureus.8705.
  2. Ahmed M, Yassin M A, Abdelmahmuod E (September 08, 2020) Steroid-Refractory Chronic IdiopathicThrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab. Cureus12(9): e10305. DOI 10.7759/cureus.10305
  3. Teofili L, Larocca LM. Advances in understanding the pathogenesis of familial thrombocythaemia. Br J Haematol. 2011 Mar;152(6):701-12. doi: 10.1111/j.1365-2141.2010.08500.x. Epub 2011 Feb 8. PMID: 21303356.
  4. Olnes MJ, Scheinberg P, Calvo KR, et al, “Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia,” N Engl J Med, 2012, 367(1):11-9. [PubMed 22762314]
  5. McHutchison JG, Dusheiko G, Schiffman ML, et al, “Eltrombopag for Thrombocytopenia in Patients With Cirrhosis Associated With Hepatitis C,” N Engl J Med, 2007, 357(22):2227-36. [PubMed 18046027]
  6. Ahmed MA, Yassin MA: Low-dose eltrombopag in a patient with chronic idiopathicthrombocytopenic purpura post sleeve gastrectomy. Case Rep Oncol. 2020, 13:655-658.10.1159/000507755